Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,652 | 53,076 | 61,428 | 69,804 | 77,616 |
| TOTAL | $50,045 | $56,584 | $62,179 | $71,298 | $80,084 |
| Non-Current Assets | |||||
| PPE Net | 21 | 24 | 27 | 31 | 34 |
| Other Non-Current Assets | 272 | 215 | 278 | 220 | 278 |
| TOTAL | $292 | $239 | $306 | $251 | $311 |
| Total Assets | $50,337 | $56,824 | $62,485 | $71,550 | $80,395 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,988 | 1,773 | 2,548 | 2,361 | 3,457 |
| Accrued Expenses | 4,513 | 5,353 | 6,267 | 8,038 | 7,533 |
| TOTAL | $6,720 | $7,317 | $9,040 | $10,598 | $11,215 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 28 | 0 | 30 | 0 | 34 |
| TOTAL | $28 | $N/A | $30 | $N/A | $34 |
| Total Liabilities | $6,748 | $7,317 | $9,070 | $10,598 | $11,249 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,099 | 1,099 | 1,073 | 1,059 | 1,059 |
| Common Shares | 22 | 1 | 21 | 21 | 21 |
| Retained earnings | -189,071 | -181,134 | -173,379 | -163,927 | -153,676 |
| Other shareholders' equity | -10,425 | -10,359 | -10,455 | -10,247 | -10,440 |
| TOTAL | $43,589 | $49,507 | $53,415 | $60,952 | $69,146 |
| Total Liabilities And Equity | $50,337 | $56,824 | $62,485 | $71,550 | $80,395 |